Immunogenicity of 2009–2010 Seasonal Influenza Vaccine in US Adults and Elderly
Author Information
Author(s): Xie Hang, Jing Xianghong, Li Xing, Lin Zhengshi, Plant Ewan, Zoueva Olga, Yang Hong, Ye Zhiping
Primary Institution: United States Food and Drug Administration
Hypothesis
How does the 2009–2010 seasonal influenza vaccine affect antibody responses in adults and the elderly?
Conclusion
The 2009–2010 seasonal influenza vaccine significantly boosted antibody responses in both adults and the elderly, particularly against pandemic H1N1 strains.
Supporting Evidence
- Over 70% of recipients reached a seroprotective titer of 40 against seasonal strains after vaccination.
- 24% of adults and 36% of elderly reached a seroprotective titer against pandemic H1N1 after vaccination.
- 22% of adults and 34% of elderly showed a 4-fold increase in HAI titers against pandemic H1N1 after vaccination.
Takeaway
The flu shot helped people make more antibodies to fight the flu, especially older folks.
Methodology
The study used hemagglutination inhibition (HAI) assays to evaluate antibody responses before and after vaccination in healthy adults and elderly participants.
Potential Biases
Potential bias due to observational study design and reliance on self-reported vaccination status.
Limitations
The study did not evaluate the long-term effectiveness of the vaccine against the pandemic strain.
Participant Demographics
120 adults aged 20.1–64.8 years and 59 elderly aged 65.4–88.2 years.
Statistical Information
P-Value
<0.0001
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website